The emergence of medications like copyright and Semaglutide signifies a major shift in how we treat blood sugar. These new therapies belong to a class known as GLP-1 receptor agonists, which replicate the effects of a natural hormone that controls glucose levels and appetite. First, developed for diabetic conditions, their effectiveness in facil… Read More